In this compelling episode, host Helen Hopkins engages in a deep conversation with Edward Armstrong, Vice President of Quality at Mustang Bio, and Matthew Lakelin, VP of Scientific Affairs at TrakCel. Both experts bring a wealth of knowledge and experience to the table, as they explore the intricacies, challenges, and benefits of Cell and Gene Therapy (CGT).

Edward’s extensive background in CGT and quality management dovetails with Matthew's expertise in scientific affairs, giving you an enriched understanding of the topic. Together, they discuss the evolution of the CGT industry, the unique challenges posed by its clinical trials, and the groundbreaking technology that is streamlining the entire process.

Tune in to learn how this rapidly changing field impacts patient care and healthcare’s future.